Perinatal Mental Health Documentation: Postpartum Depression & Anxiety
Documentation Considerations for Perinatal Mental Health
Perinatal mood and anxiety disorders (PMADs) affect approximately 1 in 5 birthing parents and are the most common complication of pregnancy and childbirth. Despite this prevalence, perinatal mental health documentation presents unique challenges: screening must be conducted with validated instruments at specific intervals, medication decisions require nuanced risk-benefit documentation, coordination with obstetric and pediatric providers is essential, and the clinical picture changes rapidly as pregnancy progresses and the postpartum period unfolds.
Effective documentation in this population captures the dynamic interplay between biological, psychological, and social factors while supporting continuity of care across the mental health and obstetric systems.
When You Need Population-Specific Documentation
Perinatal-specific documentation practices are needed when:
- The client is pregnant, postpartum (up to 12 months), or experienced a pregnancy loss and mental health symptoms are related to the perinatal period
- Perinatal mood screening (EPDS, PHQ-9, GAD-7) is being administered
- Medication decisions must account for reproductive safety during pregnancy or lactation
- Coordination with OB-GYN, midwife, or pediatrician is clinically necessary
- Intrusive thoughts about infant harm are present — a common PMAD symptom that requires careful documentation and risk assessment
- The client is considering or currently breastfeeding and medication decisions are affected
- Pregnancy loss, infertility, or birth trauma is the focus of treatment
Key Components — What to Document Differently
Perinatal Screening and Assessment
Document screening systematically:
- Instrument used — EPDS is the gold standard for perinatal depression screening; the GAD-7 or Perinatal Anxiety Screening Scale (PASS) for anxiety
- Score and date — Track across sessions to show trajectory
- Item-level follow-up — EPDS item 10 asks about self-harm; always document your clinical follow-up on this item, even when the response is 0
- Timing context — Note gestational age or weeks/months postpartum at each administration, as symptom presentation and risk change across the perinatal period
Medication Risk-Benefit Documentation
This is one of the most legally and clinically sensitive areas of perinatal documentation. When medication is discussed or managed:
- Document the informed consent conversation — that you discussed the risks of medication exposure, the risks of untreated maternal mental illness (which include preterm birth, low birth weight, impaired bonding, and developmental impacts), and alternative treatments
- Reference evidence-based resources — LactMed, MotherToBaby, reproductive psychiatry consultation
- Document the client's decision and that it was made with informed consent
- If the client declines medication, document the clinical reasoning for recommending it, the alternatives offered, and your plan for monitoring symptom severity
Intrusive Thoughts Documentation
Intrusive thoughts about infant harm are a hallmark symptom of postpartum OCD and anxiety, not a sign of danger to the infant. Document carefully:
- Nature of the thoughts — ego-dystonic (unwanted, distressing) versus ego-syntonic (desired, planned)
- The client's reaction — Does the client find the thoughts horrifying? This is characteristic of OCD/anxiety. Document the distress.
- Risk assessment — Differentiate between intrusive thoughts (common, low-risk) and psychotic symptoms with infant harm ideation (rare, high-risk). Document the features that support your assessment.
- Clinical response — Normalize when appropriate, assess risk when indicated, document both
Provider Coordination
- OB-GYN or midwife — Share screening results, symptom severity, medication recommendations, and safety concerns. Document the communication.
- Prescribing psychiatrist — If you are not the prescriber, document your recommendations to the prescriber and their responses
- Pediatrician — If the infant is exposed to medication through breastfeeding, coordination with the pediatrician may be appropriate. Document with the client's authorization.
Perinatal Therapy Session Note — Postpartum Depression and Anxiety
Client: L.M., Age 32, Female | Date: 2026-03-11 | Session #: 6 | Duration: 50 minutes | CPT: 90837
Diagnosis: F53.0 — Postpartum Depression; F41.1 — Generalized Anxiety Disorder Perinatal Status: 10 weeks postpartum, vaginal delivery without complications. Singleton infant, healthy. Currently breastfeeding exclusively.
Screening: EPDS administered today: 16 (severe range; scores above 13 indicate probable depression). Previous scores: intake (4 weeks postpartum) = 19; session 3 (7 weeks postpartum) = 17. Trajectory shows gradual improvement. EPDS Item 10 (self-harm): scored 0 ("never"). Clinical follow-up on this item: L.M. denied any thoughts of self-harm, stating, "No, I would never. My baby needs me."
GAD-7: 13 (moderate). Previous: intake = 17 (severe); session 3 = 15 (moderate-severe). Improvement consistent with treatment response.
Subjective: L.M. reported her mood is "still hard, but I have some good hours now." She described experiencing pleasure while bathing her infant for the first time since delivery — "I actually smiled and meant it." She continues to experience significant anxiety about the infant's health, checking the baby monitor repeatedly during the night even when the infant is sleeping. She reported an intrusive thought this week of "What if I drop her on the stairs" that caused significant distress. She stated, "I know I wouldn't do it, but the thought makes me feel like a terrible mother." Sleep is approximately 4 hours per night in fragmented intervals consistent with infant feeding schedule. She reported that her partner has taken over nighttime feedings twice per week using pumped breast milk, which has helped.
L.M. stated she has been considering starting sertraline as discussed with her reproductive psychiatrist (Dr. R.) but remains ambivalent due to breastfeeding concerns.
Objective / Behavioral Observations: L.M. arrived with infant in car seat. She was appropriately groomed. Infant was sleeping and L.M. checked on her twice during session — this represents a decrease from the 6-7 checks per session observed at intake. Affect was tearful when discussing her anxiety about motherhood and brighter when describing the bathing experience. She made good eye contact and engaged actively. No psychomotor agitation or retardation. Speech normal.
Assessment: L.M. demonstrates a mixed postpartum depression and anxiety presentation that is gradually improving with therapy. EPDS and GAD-7 scores show consistent downward trajectory. The intrusive thought about dropping the infant is ego-dystonic, causes significant distress, and is consistent with postpartum anxiety/OCD — not with risk of harm to the infant. L.M.'s distress about the thought and her immediate rejection of it as "something I would never do" are clinically reassuring. The decreased frequency of infant checking in session (from 6-7 to 2 times) represents behavioral improvement in anxiety management.
The medication decision remains a clinically significant issue. L.M.'s symptoms, while improving, remain in the moderate-to-severe range and may benefit from pharmacological augmentation of therapy. Her ambivalence about sertraline while breastfeeding is understandable and warrants continued informed discussion.
Interventions:
- CBT for perinatal depression: Behavioral activation — reviewed the "bathing" experience as evidence that pleasurable experiences are becoming accessible. Identified two additional activities to pursue this week (walking with infant, calling a friend during a feeding).
- CBT for intrusive thoughts: Psychoeducation on intrusive thoughts as a feature of postpartum anxiety, not an indicator of danger to the infant. Normalized the experience — up to 91% of new parents report intrusive thoughts about infant harm. Introduced cognitive defusion strategy: labeling the thought as "my anxiety talking" rather than engaging with the content. L.M. reported immediate relief at learning intrusive thoughts are common.
- Medication discussion: Reviewed the evidence on sertraline and breastfeeding — sertraline is first-line for perinatal depression, levels in breast milk are very low (referenced LactMed), and the AAP considers it compatible with breastfeeding. Discussed the risks of continued untreated moderate-severe depression on maternal-infant bonding and infant development. L.M. stated she wants to discuss with her partner before making a decision. Respected this.
Coordination of Care: Spoke with Dr. R. (reproductive psychiatrist) on 2026-03-10 per signed ROI. Dr. R. confirmed sertraline 50mg would be the starting recommendation if L.M. decides to proceed. Dr. R. will follow up with L.M. directly at their scheduled appointment on 2026-03-18.
Sent EPDS scores and treatment summary to Dr. N. (OB-GYN) per signed ROI on 2026-03-11.
Plan: Continue weekly CBT. Next session: follow up on medication decision, continue behavioral activation, introduce formal thought record for intrusive thoughts. Administer EPDS and GAD-7 in 4 weeks. If symptoms do not continue to improve, will more strongly recommend medication augmentation.
Risk Assessment: L.M. denied suicidal ideation, self-harm, and intent to harm her infant. Intrusive thoughts are ego-dystonic and consistent with postpartum anxiety, not psychosis. No evidence of psychotic features (hallucinations, delusions, disorganized thinking). Infant bonding shows improvement. Risk level: low. Safety plan in place (partner, mother available as support; Postpartum Support International helpline number provided). Monitor for any emergence of psychotic symptoms given the early postpartum period.
This is a sample for educational purposes only — not real patient data.
Best Practices
Screen at every visit and document the scores. Perinatal symptoms can escalate rapidly. A client who scored 10 on the EPDS two weeks ago may score 18 today. Consistent screening creates a documented trajectory that supports clinical decision-making.
Always follow up on EPDS item 10. Even when the score is 0, document that you inquired about self-harm. This protects you clinically and legally, and it normalizes the question for clients who may not disclose spontaneously.
Document the informed consent process for medication decisions with specificity. This is a high-liability area. Documenting that you "discussed medication" is insufficient. Document what medication was discussed, what evidence was reviewed, what risks were presented (both of the medication and of untreated illness), and the client's informed decision.
Differentiate intrusive thoughts from psychosis in writing. This distinction is clinically critical and potentially life-saving. Ego-dystonic intrusive thoughts are common and low-risk. Psychotic symptoms with infant harm content are rare and constitute a psychiatric emergency. Your documentation should make clear which you assessed and how you differentiated.
Coordinate across providers and document everything. Perinatal mental health treatment involves a team — therapist, prescriber, OB-GYN, sometimes pediatrician. Your documentation should reflect this coordination and create a clear record of what was communicated to whom.
Common Mistakes
Failing to screen with a validated instrument. Clinical impression alone is insufficient for perinatal depression screening. Use a validated tool and document it. "Client seemed depressed" is not screening.
Not documenting the perinatal timeline. Gestational age or postpartum timing is clinically essential — the risk profile, differential diagnosis, and treatment approach differ at 8 weeks pregnant versus 8 weeks postpartum. Always note the perinatal timeframe.
Pathologizing normal postpartum distress. Not every tearful new parent has a PMAD. Document the features that distinguish clinical disorder from adjustment — duration beyond 2 weeks, functional impairment, severity of symptoms, and specific PMAD features.
Ignoring the partner or co-parent. Partners of perinatal clients experience elevated rates of depression and anxiety. While the partner is not your client (unless you are treating them), note their functioning when relevant to the client's support system and recovery.
Insufficient medication documentation. "Client started Zoloft" does not capture the clinical picture. Document who prescribed it, the dose, the informed consent conversation, the breastfeeding status and its relevance, and the monitoring plan.
Overlooking birth trauma. Some clients develop PTSD related to traumatic birth experiences. This is a distinct clinical entity from postpartum depression and requires trauma-focused treatment. Document birth trauma as a specific presenting concern when present.
Writing a progress note right now?
My Clinical Writer helps you generate progress notes from your session details in under 60 seconds.
Try My Clinical Writer Free →myclinicalwriter.ai
Frequently Asked Questions
Related Templates
External Resources
Authoritative references and tools related to this documentation type.
Stop spending hours on documentation
My Clinical Writer uses AI to help you draft clinical notes, treatment plans, and reports in minutes — not hours.
Get Started at myclinicalwriter.ai →